Jason S. Lewis Department of Radiology Memorial Sloan Kettering Cancer Center Biography Publications Institution JoVE Articles Jason S. Lewis has not added a biography. If you are Jason S. Lewis and would like to personalize this page please email our Author Liaison for assistance. Publications Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Dec, 2014 | Pubmed ID: 25453051 Chemoenzymatic Strategy for the Synthesis of Site-specifically Labeled Immunoconjugates for Multimodal PET and Optical Imaging Bioconjugate Chemistry. Dec, 2014 | Pubmed ID: 25418333 Synthesis and Evaluation of (18)F-labeled ATP Competitive Inhibitors of Topoisomerase II As Probes for Imaging Topoisomerase II Expression European Journal of Medicinal Chemistry. Oct, 2014 | Pubmed ID: 25240701 What a Difference a Carbon Makes: H₄octapa Vs H₄C3octapa, Ligands for In-111 and Lu-177 Radiochemistry Inorganic Chemistry. Oct, 2014 | Pubmed ID: 25192223 ⁸⁹Zr-huJ591 Immuno-PET Imaging in Patients with Advanced Metastatic Prostate Cancer European Journal of Nuclear Medicine and Molecular Imaging. Nov, 2014 | Pubmed ID: 25143071 CDK9-mediated Transcription Elongation is Required for MYC Addiction in Hepatocellular Carcinoma Genes & Development. Aug, 2014 | Pubmed ID: 25128497 A Modular Labeling Strategy for in Vivo PET and Near-infrared Fluorescence Imaging of Nanoparticle Tumor Targeting Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Oct, 2014 | Pubmed ID: 25060196 Targeting Breast Tumors with PH (low) Insertion Peptides Molecular Pharmaceutics. Aug, 2014 | Pubmed ID: 25004202 Development of a Minimal Saponin Vaccine Adjuvant Based on QS-21 Nature Chemistry. Jul, 2014 | Pubmed ID: 24950335 In Vivo Imaging of GLP-1R with a Targeted Bimodal PET/fluorescence Imaging Agent Bioconjugate Chemistry. Jul, 2014 | Pubmed ID: 24856928 Alternative Chelator for ⁸⁹Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO) Journal of Medicinal Chemistry. Jun, 2014 | Pubmed ID: 24814511 Building Blocks for the Construction of Bioorthogonally Reactive Peptides Via Solid-Phase Peptide Synthesis ChemistryOpen. Apr, 2014 | Pubmed ID: 24808990 Understanding the Pharmacological Properties of a Metabolic PET Tracer in Prostate Cancer Proceedings of the National Academy of Sciences of the United States of America. May, 2014 | Pubmed ID: 24785505 Noninvasive Imaging of PSMA in Prostate Tumors with (89)Zr-Labeled HuJ591 Engineered Antibody Fragments: the Faster Alternatives Molecular Pharmaceutics. Nov, 2014 | Pubmed ID: 24779727 Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-negative Breast Cancer Science Signaling. Mar, 2014 | Pubmed ID: 24667376 Pairwise Comparison of 89Zr- and 124I-labeled CG250 Based on Positron Emission Tomography Imaging and Nonlinear Immunokinetic Modeling: in Vivo Carbonic Anhydrase IX Receptor Binding and Internalization in Mouse Xenografts of Clear-cell Renal Cell Carcinoma European Journal of Nuclear Medicine and Molecular Imaging. May, 2014 | Pubmed ID: 24604591 Imaging the Norepinephrine Transporter in Neuroblastoma: a Comparison of [18F]-MFBG and 123I-MIBG Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2014 | Pubmed ID: 24573553 Influence of Free Fatty Acids on Glucose Uptake in Prostate Cancer Cells Nuclear Medicine and Biology. Mar, 2014 | Pubmed ID: 24440212 Underscoring the Influence of Inorganic Chemistry on Nuclear Imaging with Radiometals Inorganic Chemistry. Feb, 2014 | Pubmed ID: 24313747 Synthesis and Evaluation of 18F-labeled Benzylguanidine Analogs for Targeting the Human Norepinephrine Transporter European Journal of Nuclear Medicine and Molecular Imaging. Feb, 2014 | Pubmed ID: 24173571 A Prospective Pilot Study of (89)zr-j591/prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy The Journal of Urology. May, 2014 | Pubmed ID: 24135437 H6phospa-trastuzumab: Bifunctional Methylenephosphonate-based Chelator with 89Zr, 111In and 177Lu Dalton Transactions (Cambridge, England : 2003). Jan, 2014 | Pubmed ID: 24104523 (18)F-labeled-bioorthogonal Liposomes for in Vivo Targeting Bioconjugate Chemistry. Nov, 2013 | Pubmed ID: 24180480 Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Nov, 2013 | Pubmed ID: 24029655 Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Oct, 2013 | Pubmed ID: 23970364 H(4)octapa-trastuzumab: Versatile Acyclic Chelate System for 111In and 177Lu Imaging and Therapy Journal of the American Chemical Society. Aug, 2013 | Pubmed ID: 23901833 Sandmeyer Reaction Repurposed for the Site-selective, Non-oxidizing Radioiodination of Fully-deprotected Peptides: Studies on the Endogenous Opioid Peptide α-neoendorphin Bioorganic & Medicinal Chemistry Letters. Aug, 2013 | Pubmed ID: 23796454 Fatty Acid Synthase is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate As a Predictor of the Targeted Therapy Outcome PloS One. 2013 | Pubmed ID: 23741342 A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2013 | Pubmed ID: 23708196 Enzyme-mediated Methodology for the Site-specific Radiolabeling of Antibodies Based on Catalyst-free Click Chemistry Bioconjugate Chemistry. Jun, 2013 | Pubmed ID: 23688208 The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jun, 2013 | Pubmed ID: 23616581 Monitoring Afatinib Treatment in HER2-positive Gastric Cancer with 18F-FDG and 89Zr-trastuzumab PET Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jun, 2013 | Pubmed ID: 23578997 Antilipolytic Drug Boosts Glucose Metabolism in Prostate Cancer Nuclear Medicine and Biology. May, 2013 | Pubmed ID: 23454248 Imaging Tumor Burden in the Brain with 89Zr-Transferrin Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jan, 2013 | Pubmed ID: 23236019 PET Imaging with ⁸⁹Zr: from Radiochemistry to the Clinic Nuclear Medicine and Biology. Jan, 2013 | Pubmed ID: 22998840 (89)Zr-Labeled Paramagnetic Octreotide-Liposomes for PET-MR Imaging of Cancer Pharmaceutical Research. Dec, 2012 | Pubmed ID: 23224977 H(2)azapa: a Versatile Acyclic Multifunctional Chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu Inorganic Chemistry. Nov, 2012 | Pubmed ID: 23106422 Annotating MYC Status with 89Zr-transferrin Imaging Nature Medicine. Oct, 2012 | Pubmed ID: 23001181 An Improved Strategy for the Synthesis of [¹⁸F]-labeled Arabinofuranosyl Nucleosides Nuclear Medicine and Biology. Nov, 2012 | Pubmed ID: 22819195 Efficient (18)F-labeling of Large 37-amino-acid PHLIP Peptide Analogues and Their Biological Evaluation Bioconjugate Chemistry. Aug, 2012 | Pubmed ID: 22784215 Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-specific Antigen Cancer Discovery. Apr, 2012 | Pubmed ID: 22576209 89Zr-labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging Bioconjugate Chemistry. Dec, 2011 | Pubmed ID: 22035047 Affinity-based Proteomics Reveal Cancer-specific Networks Coordinated by Hsp90 Nature Chemical Biology. Nov, 2011 | Pubmed ID: 21946277 Targeting the Internal Epitope of Prostate-specific Membrane Antigen with 89Zr-7E11 Immuno-PET Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Oct, 2011 | Pubmed ID: 21908391 Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels-Alder Click Chemistry Bioconjugate Chemistry. Oct, 2011 | Pubmed ID: 21877749 The Synthesis and Evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET Radiotracer Designed for the Delineation of Histone Deacetylase Expression in Cancer Nuclear Medicine and Biology. Jul, 2011 | Pubmed ID: 21718944 The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology Seminars in Nuclear Medicine. Jul, 2011 | Pubmed ID: 21624561 Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions Molecular Imaging. Jun, 2011 | Pubmed ID: 21496448 A Practical Guide to the Construction of Radiometallated Bioconjugates for Positron Emission Tomography Dalton Transactions (Cambridge, England : 2003). Jun, 2011 | Pubmed ID: 21442098 Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-albumin As a Model System Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Apr, 2011 | Pubmed ID: 21421727 Role of Metalation in the Topoisomerase IIα Inhibition and Antiproliferation Activity of a Series of α-heterocyclic-N4-substituted Thiosemicarbazones and Their Cu(II) Complexes Journal of Medicinal Chemistry. Apr, 2011 | Pubmed ID: 21391686 Imaging and Treating Tumor Vasculature with Targeted Radiolabeled Carbon Nanotubes International Journal of Nanomedicine. 2010 | Pubmed ID: 21042424 89Zr-DFO-J591 for ImmunoPET of Prostate-specific Membrane Antigen Expression in Vivo Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2010 | Pubmed ID: 20660376 Cerenkov Luminescence Imaging of Medical Isotopes Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jul, 2010 | Pubmed ID: 20554722 Improved Synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU) Nuclear Medicine and Biology. May, 2010 | Pubmed ID: 20447555 Clickable Bifunctional Radiometal Chelates for Peptide Labeling Chemical Communications (Cambridge, England). Mar, 2010 | Pubmed ID: 20177623 Unconventional Nuclides for Radiopharmaceuticals Molecular Imaging. Feb, 2010 | Pubmed ID: 20128994 Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using Zr-DFO-trastuzumab PloS One. 2010 | Pubmed ID: 20111600 Nitroimidazole Conjugates of Bis(thiosemicarbazonato)64Cu(II) - Potential Combination Agents for the PET Imaging of Hypoxia Journal of Inorganic Biochemistry. Feb, 2010 | Pubmed ID: 19932509 Standardized Methods for the Production of High Specific-activity Zirconium-89 Nuclear Medicine and Biology. Oct, 2009 | Pubmed ID: 19720285 Melanoma Imaging Using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH Nuclear Medicine and Biology. May, 2009 | Pubmed ID: 19423001 A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography Cancer Research. May, 2009 | Pubmed ID: 19417132 Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. May, 2009 | Pubmed ID: 19380404 (64)Cu-labeled CB-TE2A and Diamsar-conjugated RGD Peptide Analogs for Targeting Angiogenesis: Comparison of Their Biological Activity Nuclear Medicine and Biology. Apr, 2009 | Pubmed ID: 19324273 Bromination from the Macroscopic Level to the Tracer Radiochemical Level: (76)Br Radiolabeling of Aromatic Compounds Via Electrophilic Substitution Bioconjugate Chemistry. Apr, 2009 | Pubmed ID: 19260733 In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor-bearing Nude Mice Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Mar, 2009 | Pubmed ID: 19223400 Synthesis and Characterization of the Copper(II) Complexes of New N2S2-donor Macrocyclic Ligands: Synthesis and in Vivo Evaluation of the (64)Cu Complexes Dalton Transactions (Cambridge, England : 2003). Jan, 2009 | Pubmed ID: 19081987 Tumor Hypoxia Detected by Positron Emission Tomography with 60Cu-ATSM As a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: a Pilot Study Diseases of the Colon and Rectum. Nov, 2008 | Pubmed ID: 18682881 Autoradiographic and Small-animal PET Comparisons Between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the Hypoxic Selective (64)Cu-ATSM in a Rodent Model of Cancer Nuclear Medicine and Biology. Aug, 2008 | Pubmed ID: 18678357 Evaluation of a Bromine-76-labeled Progestin 16alpha,17alpha-dioxolane for Breast Tumor Imaging and Radiotherapy: in Vivo Biodistribution and Metabolic Stability Studies Nuclear Medicine and Biology. Aug, 2008 | Pubmed ID: 18678350 An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jul, 2008 | Pubmed ID: 18552145 In Vitro and in Vivo Evaluation of Bifunctional Bisthiosemicarbazone 64Cu-complexes for the Positron Emission Tomography Imaging of Hypoxia Journal of Medicinal Chemistry. May, 2008 | Pubmed ID: 18416544 Examining the Relationship Between Cu-ATSM Hypoxia Selectivity and Fatty Acid Synthase Expression in Human Prostate Cancer Cell Lines Nuclear Medicine and Biology. Apr, 2008 | Pubmed ID: 18355682 1-11C-acetate As a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Feb, 2008 | Pubmed ID: 18199615 Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-labeled Diacetyl-bis(N4-methylthiosemicarbazone) Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Feb, 2008 | Pubmed ID: 18199612 Synthesis, in Vitro and in Vivo Characterization of (64)Cu(I) Complexes Derived from Hydrophilic Tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane Ligands Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry. Feb, 2008 | Pubmed ID: 18043951 Radiometal-labeled Somatostatin Analogs for Applications in Cancer Imaging and Therapy Methods in Molecular Biology (Clifton, N.J.). 2007 | Pubmed ID: 18604948 Gallium-68-labeled DOTA-rhenium-cyclized Alpha-melanocyte-stimulating Hormone Analog for Imaging of Malignant Melanoma Nuclear Medicine and Biology. Nov, 2007 | Pubmed ID: 17998097 Cu-ATSM: a Radiopharmaceutical for the PET Imaging of Hypoxia Dalton Transactions (Cambridge, England : 2003). Nov, 2007 | Pubmed ID: 17992274 Molecular Imaging of Gastrin-releasing Peptide Receptor-positive Tumors in Mice Using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14) Bioconjugate Chemistry. May-Jun, 2007 | Pubmed ID: 17378600 In Vivo Imaging in a Murine Model of Glioblastoma Neurosurgery. Feb, 2007 | Pubmed ID: 17290188 Synthesis and Biologic Evaluation of 64Cu-labeled Rhenium-cyclized Alpha-MSH Peptide Analog Using a Cross-bridged Cyclam Chelator Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jan, 2007 | Pubmed ID: 17204700 Imaging Oxygenation of Human Tumours European Radiology. Apr, 2007 | Pubmed ID: 17043737 64Cu-azabicyclo[3.2.2]nonane Thiosemicarbazone Complexes: Radiopharmaceuticals for PET of Topoisomerase II Expression in Tumors Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Dec, 2006 | Pubmed ID: 17138747 Hypoxia: Importance in Tumor Biology, Noninvasive Measurement by Imaging, and Value of Its Measurement in the Management of Cancer Therapy International Journal of Radiation Biology. Oct, 2006 | Pubmed ID: 17118889 Validation of a Novel CHX-A'' Derivative Suitable for Peptide Conjugation: Small Animal PET/CT Imaging Using Yttrium-86-CHX-A''-octreotide Journal of Medicinal Chemistry. Jul, 2006 | Pubmed ID: 16821789 Assessment of Myocardial Metabolism in Diabetic Rats Using Small-animal PET: a Feasibility Study Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Apr, 2006 | Pubmed ID: 16595504 Three-dimensional Maximum a Posteriori (MAP) Imaging with Radiopharmaceuticals Labeled with Three Cu Radionuclides Nuclear Medicine and Biology. Feb, 2006 | Pubmed ID: 16546676 In Vivo Skeletal Imaging of 18F-fluoride with Positron Emission Tomography Reveals Damage- and Time-dependent Responses to Fatigue Loading in the Rat Ulna Bone. Aug, 2006 | Pubmed ID: 16533624 Assessment of Myocardial Blood Flow Using 15O-water and 1-11C-acetate in Rats with Small-animal PET Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Mar, 2006 | Pubmed ID: 16513617 Minimally Invasive Method of Determining Blood Input Function from PET Images in Rodents Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Feb, 2006 | Pubmed ID: 16455640 Preparation of High Specific Activity (86)Y Using a Small Biomedical Cyclotron Nuclear Medicine and Biology. Nov, 2005 | Pubmed ID: 16253815 Measurement of Input Functions in Rodents: Challenges and Solutions Nuclear Medicine and Biology. Oct, 2005 | Pubmed ID: 16243642 Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-based Radiotherapy of Prostate Cancer Cancer Research. Sep, 2005 | Pubmed ID: 16166318 Cell Line-dependent Differences in Uptake and Retention of the Hypoxia-selective Nuclear Imaging Agent Cu-ATSM Nuclear Medicine and Biology. Aug, 2005 | Pubmed ID: 16026709 A Tat Fusion Protein-based Tumor Vaccine for Breast Cancer Annals of Surgical Oncology. Jul, 2005 | Pubmed ID: 15889213 Positron-emitting Isotopes Produced on Biomedical Cyclotrons Current Medicinal Chemistry. 2005 | Pubmed ID: 15853713 Imaging of Melanoma Using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a Cyclized Peptide Analogue of Alpha-MSH Journal of Medicinal Chemistry. Apr, 2005 | Pubmed ID: 15828837 Assessment of Regional Tumor Hypoxia Using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) Positron Emission Tomography: Comparative Study Featuring MicroPET Imaging, Po2 Probe Measurement, Autoradiography, and Fluorescent Microscopy in the R3327-AT and FaDu Rat Tumor Models International Journal of Radiation Oncology, Biology, Physics. Apr, 2005 | Pubmed ID: 15817355 Dosimetry of 60/61/62/64Cu-ATSM: a Hypoxia Imaging Agent for PET European Journal of Nuclear Medicine and Molecular Imaging. Jul, 2005 | Pubmed ID: 15785955 Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) Complexes As Hypoxia Imaging Agents Nuclear Medicine and Biology. Feb, 2005 | Pubmed ID: 15721760 Basic Characterization of 64Cu-ATSM As a Radiotherapy Agent Nuclear Medicine and Biology. Jan, 2005 | Pubmed ID: 15691658 Enhancing Targeted Radiotherapy by Copper(II)diacetyl- Bis(N4-methylthiosemicarbazone) Using 2-deoxy-D-glucose Cancer Research. Sep, 2003 | Pubmed ID: 14500386 Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate As Potential Folate-receptor-targeted PET Radiopharmaceuticals Nuclear Medicine and Biology. Oct, 2003 | Pubmed ID: 14499330 [Tc(CO)(3)](+) Chemistry: a Promising New Concept for SPECT? Against European Journal of Nuclear Medicine and Molecular Imaging. Sep, 2003 | Pubmed ID: 12898205 Intra-tumoral Distribution of (64)Cu-ATSM: a Comparison Study with FDG Nuclear Medicine and Biology. Jul, 2003 | Pubmed ID: 12831991 In Vivo Assessment of Tumor Hypoxia in Lung Cancer with 60Cu-ATSM European Journal of Nuclear Medicine and Molecular Imaging. Jun, 2003 | Pubmed ID: 12692685 Assessing Tumor Hypoxia in Cervical Cancer by Positron Emission Tomography with 60Cu-ATSM: Relationship to Therapeutic Response-a Preliminary Report International Journal of Radiation Oncology, Biology, Physics. Apr, 2003 | Pubmed ID: 12654432 Molecular Imaging: the Application of Small Animal Positron Emission Tomography Journal of Cellular Biochemistry. Supplement. 2002 | Pubmed ID: 12552610 Delineation of Hypoxia in Canine Myocardium Using PET and Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Nov, 2002 | Pubmed ID: 12411560 Small Animal Imaging. Current Technology and Perspectives for Oncological Imaging European Journal of Cancer (Oxford, England : 1990). Nov, 2002 | Pubmed ID: 12387842 DOTA-D-Tyr(1)-octreotate: a Somatostatin Analogue for Labeling with Metal and Halogen Radionuclides for Cancer Imaging and Therapy Bioconjugate Chemistry. Jul-Aug, 2002 | Pubmed ID: 12121126 Copper Bis(thiosemicarbazone) Complexes As Hypoxia Imaging Agents: Structure-activity Relationships Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry. Mar, 2002 | Pubmed ID: 11935349 Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the Prevention of Tumor Growth at Wound Sites Following Laparoscopic Surgery: Monitoring Therapy Response with MicroPET and Magnetic Resonance Imaging Cancer Research. Jan, 2002 | Pubmed ID: 11809694 O bioconjugação e radiossíntese de Brian M. Zeglis1, Jason S. Lewis1 1Department of Radiology, Memorial Sloan Kettering Cancer Center Chemistry Aproveitando a demanda Bioorthogonal Inverse Electron Diels-Alder para Pretargeted PET Imagem Thomas Reiner*1, Jason S. Lewis1, Brian M. Zeglis*1 1Department of Radiology, Memorial Sloan Kettering Cancer Center Bioengineering
O bioconjugação e radiossíntese de Brian M. Zeglis1, Jason S. Lewis1 1Department of Radiology, Memorial Sloan Kettering Cancer Center Chemistry
Aproveitando a demanda Bioorthogonal Inverse Electron Diels-Alder para Pretargeted PET Imagem Thomas Reiner*1, Jason S. Lewis1, Brian M. Zeglis*1 1Department of Radiology, Memorial Sloan Kettering Cancer Center Bioengineering